Zusammenfassung
Bei der Rhabdomyolyse kommt es zu einer Freisetzung von Muskelzellbestandteilen in den Blutkreislauf nach direkter Schädigung des Sarkolemms bzw. Ausfall der Energieversorgung innerhalb der Muskelzelle mit Anstieg potenziell toxischer Muskelzellbestandteile, Kreatinkinase (CK) und Myoglobin im Serum. Das häufige Auftreten einer assoziierten Myoglobinurie führte dazu, dass die Begriffe Rhabdomyolyse und Myoglobinurie oft synonym verwandt wurden. Komplikationen der Rhabdomyolyse sind akutes Nierenversagen, Hyperkaliämie mit Herzstillstand, disseminierte intravasale Gerinnungsstörung oder lokal ein akutes Kompartmentsyndrom. Das Krankheitsbild ist hinsichtlich der Ätiologie sehr heterogen und kann durch eine Vielzahl unterschiedlicher Erkrankungen, die zu einer Schädigung der Muskelzellmembranen, Ionenkanäle oder der muskulären Einergieversorgung führen, hervorgerufen werden.
Summary
Rhabdomyolysis is a disorder characterized by acute damage of the sarcolemma of the skeletal muscle leading to release of potentially toxic muscle cell components into the circulation, most notably creatine phosphokinase (CK) and myoglobin, and is frequently accompanied by myoglobinuria. Therefore, the term myoglobinuria is often used interchangeably with the term rhabdomyolysis. This disorder may result in potential life-threatening complications such as acute myoglobinuric renal failure, hyperkalemia and cardiac arrest, disseminated intravascular coagulation, and compartment syndrome. The condition is etiologically heterogeneous and may result from a large variety of diseases affecting muscle membranes, membrane ion channels, and muscle energy supply including acquired causes (e.g., exertion, crush injury and trauma, alcoholism, drugs, and toxins) and hereditary causes (e.g., disorders of carbohydrate metabolism, disorders of lipid metabolism, or diseases of the muscle associated with malignant hyperthermia). In many patients with idiopathic recurrent rhabdomyolysis, specific inherited metabolic defects have not been recognized up to now.
Literatur
Abe K, Mezaki T, Hirono N, Udaka F, Kameyama M (1990) A case of anorexia nervosa with acute renal failure resulting from rhabdomyolysis. Acta Neurol Scand 81(1):82–3
Adnet P, Lestavel P, Krivosic-Horber R (2000) Neuroleptic malignant syndrome. Br J Anaesth 85(1):129–35
Andreu AL, Bruno C, Dunne TC et al. (1999) A nonsense mutation (G15059A) in the cytochrome b gene in a patient with exercise intolerance and myoglobinuria. Ann Neurol 45(1):127–30
Better OS, Stein JH (1990) Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Engl J Med 322:825–829
Bierbach H, Bohl J, Goldner HJ, Majdandzic J (1983) Hypokalemic rhabdomyolysis associated with Bartter's syndrome. Klin Wochenschr 61(4):183–6
Billis AG, Kastanakis S, Giamarellou H, Daikos GK (1971) Acute renal failure after a meal of quail. Lancet 25:702
Bodner RA, Lynch T, Lewis L, Kahn D (1995) Serotonin syndrome. Neurology 45(2):219–23
Bloom AI, Zamir G, Muggia M, Friedlaender M, Gimmon Z, Rivkind A (1995) Torture rhabdomyorhexis—a pseudo-crush syndrome. J Trauma 38(2):252–4
Bouchama A, Knochel JP (2002) Heat stroke. N Engl J Med 346(25):1978–88
Braakhekke JP, de Bruin MI, Stegeman DF, Wevers RA, Binkhorst RA, Joosten EM (1986) The second wind phenomenon in McArdle's disease. Brain 109:1087–101
Brumback RA, Feeback DL, Leech RW (1992) Rhabdomyolysis in childhood. A primer on normal muscle function and selected metabolic myopathies characterized by disordered energy production. Pediatr Clin North Am 39(4):821–58
Buchholz U, Mouzin E, Dickey R, Moolenaar R, Sass N, Mascola L (2000) Haff disease: from the Baltic Sea to the U.S. shore. Emerg Infect Dis 6(2):192–5
Buckingham BA, Roe TF, Yoon JW (1981) Rhabdomyolysis in diabetic ketoacidosis. Am J Dis Child 135(4):352–4
Buckley PF, Hutchinson M (1995) Neuroleptic malignant syndrome. J Neurol Neurosurg Psychiatry 58(3):271–3
Campion DS, Arias JM, Carter NW (1972) Rhabdomyolysis and myoglobinuria. Association with hypokalemia of renal tubular acidosis. JAMA 220(7):967–9
Caroff SN, Mann SC, Lazarus A (1987) Neuroleptic malignant syndrome. Arch Gen Psychiatry 44(9):838–40
Caroff SN, Mann SC (1988) Neuroleptic malignant syndrome. Psychopharmacol Bull 24(1):25–9
Carrier HN, Berthillier G (1980) Carnitine levels in normal children and adults and in patients with diseases muscle. Muscle Nerve 3(4):326–34
Chaikin H (1980) Rhabdomyolysis secondary to drug overdose and prolonged coma. South Med J 73(8):990–4
Chan BS, Graudins A, Whyte IM, Dawson AH, Braitberg G, Duggin GG (1998) Serotonin syndrome resulting from drug interactions. Med J Aust 16;169(10):523–5
Chinnery PF, Johnson MA, Taylor RW, Lightowlers RN, Turnbull DM (1997) A novel mitochondrial tRNA phenylalanine mutation presenting with acute rhabdomyolysis. Ann Neurol 41(3):408–10
Christensen TE, Saxtrup O, Hansen TI et al. (1983) Familial myoglobinuria. A study of muscle and kidney pathophysiology in three brothers. Dan Med Bull 30(2):112–5
David WS (2000) Myoglobinuria. Neurol Clin 18(1):215–43
Deighan CJ, Wong KM, McLaughlin KJ, Harden P (2000) Rhabdomyolysis and acute renal failure resulting from alcohol and drug abuse. QJM 93(1):29–33
Deschauer M, Wieser T, Schroder R, Zierz S (2002) A novel nonsense mutation (515del4) in muscle carnitine palmitoyltransferase II deficiency. Mol Genet Metab 75(2):181–5
DiDonato S (1994) Disorders of lipid metabolism affecting skeletal muscle: carnitine deficiency syndrome, defects in catabolic pathway, and chanartin disease. In: Engel AG, Franzini-Armstrong C (eds) Myology. 2nd ed. McGraw-Hill, New York, pp 1587–1609
DiMauro S, Tsujino S (1994) Nonlysosomal glycogenoses. In: Engel AG, Franzini-Armstrong C (eds) Myology, Vol 2. Mc-Graw-Hill, New York, pp 1554–1576
Engel AG, Potter CS, Rosevaer JW (1964) Nucleotides and adenosine monophosphate activity of muscle in primary hypokalemic periodic paralysis. Nature 202:670–672
Engel, AG, Rebouche CJ (1982) Pathogenetic mechanisms in human carnitine deficiency syndromes. In: DL Schotland (ed) Disorders of the Motor Unit. Wiley, New York, pp 643–656
Fernandez-Sola J, Sacanella E, Estruch R, Nicolas JM, Grau JM, Urbano-Marquez A (1995) Significance of type II fiber atrophy in chronic alcoholic myopathy. J Neurol Sci 130(1):69–76
Fishbein WN (1985) Myoadenylate deaminase deficiency: inherited and acquired forms. Biochem Med 33(2):158–69
Gabow PA, Kaehny WD, Kelleher SP (1982) The spectrum of rhabdomyolysis. Medicine (Baltimore) 61(3):141–52
Gronert GA (1994) Malignant hyperthermia. In: Engel AG, Franzini-Armstrong C (eds) Myology, 2nd edn. McGraw-Hill, New York, pp 1661–1678
Haller RG, Lewis SF (1991) Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency. N Engl J Med 324(6):364–9
Halverson PB, Kozin F, Ryan LM, Sulaiman AR (1979) Rhabdomyolysis and renal failure in hypothyroidism. Ann Intern Med 91(1):57–8
Hara H, Wakayama Y, Kouno Y, Yamada H, Tanaka M, Ozawa T (1994) Acute peripheral neuropathy, rhabdomyolysis, and severe lactic acidosis associated with 3243 A to G mitochondrial DNA mutation. J Neurol Neurosurg Psychiatry 57(12):1545–6
Haslinger B, Küchle, Sitter T, Held E (2001) Alkoholabusus mit Krampfanfall als Auslöser einer Rhabdomyolyse mit akutem Nierenversagen bei McArdle-Syndrom. Dtsch Med Wochenschr 126:1265–1268
Hed R, Lundmark C, Fahlgren H, Orrel S (1962) Acute muscular syndrome in alcoholism. Acta Med Scan 171:585
Heiman-Patterson TD (1993) Neuroleptic malignant syndrome and malignant hyperthermia. Important issues for the medical consultant. Med Clin North Am 77(2):477–92
Hodel C (2002) Myopathy and rhabdomyolysis with lipid-lowering drugs. Toxicol Lett 10;128(1–3):159–68
Hogan K (1998) The anesthetic myopathies and malignant hyperthermias. Curr Opin Neurol 11(5):469–76
Honda N (1983) Acute renal failure and rhabdomyolysis. Kidney Int 23(6):888–98
Jolly BT, Talbot-Stern J (1995) Rhabdomyolysis secondary to keyboard overuse: occupational hazard of the computer age. Am J Emerg Med 13(6):644–6
Kar NC, Pearson CM (1981) Muscle adenylate deaminase deficiency. Report of six new cases. Arch Neurol 38(5):279–81
Karadimas CL, Greenstein P, Sue CM et al. (2000) Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mitochondrial DNA. Neurology 12;55(5):644–9
Kazemi-Esfarajani P, Skomorwska E, Dysgaard, Jensen T (2000) No need for ischemia in the forearm exercise test for McArdle`s disease. Neurology 54 [Suppl 3]: A332
Kazemi-Esfarjani P, Skomorowska E, Jensen TD, Haller RG, Vissing J (2002) A nonischemic forearm exercise test for McArdle disease. Ann Neurol 52(2):153–9
Kelemen J, Rice DR, Bradley WG, Munsat TL, DiMauro S, Hogan EL (1982) Familial myoadenylate deaminase deficiency and exertional myalgia. Neurology 32(8):857–63
Kelly KJ, Garland JS, Tang TT, Shug AL, Chusid MJ (1989) Fatal rhabdomyolysis following influenza infection in a girl with familial carnitine palmityl transferase deficiency. Pediatrics 84(2):312–6
Khan M, Farver D (2000) Recognition, assessment and management of neuroleptic malignant syndrome. S D J Med 53(9):395–400
King JO, Denborough MA (1973) Anesthetic-induced malignant hyperpyrexia in children. J Pediatr 83(1):37–40
Knochel JP (1982) Rhabdomyolysis and myoglobinuria. Annu Rev Med 33:435–43
Knochel JP (1990) Catastrophic medical events with exhaustive exercise: "white collar rhabdomyolysis". Kidney Int 38(4):709–19
Knochel JP (1993) Mechanisms of rhabdomyolysis. Curr Opin Rheumatol 5(6):725–31
Kornhuber J, Weller M (1994) Neuroleptic malignant syndrome. Curr Opin Neurol 7(4):353–7
Lambert C, Blanloeil Y, Horber RK, Berard L, Reyford H, Pinaud M (1994) Malignant hyperthermia in a patient with hypokalemic periodic paralysis. Anesth Analg 79(5):1012–1014
Lindner A, Hofmann E, Naumann M, Becker G, Reichmann H (1997) Clinical, morphological, biochemical, and neuroradiological features of mitochondrial encephalomyopathies. Presentation of 19 patients. Mol Cell Biochem 174(1–2):297–303
Lindner A, Reichert N, Eichhorn M, Zierz S (2001) Acute compartment syndrome after forearm ischemic work test in a patient with McArdle`s disease. Neurology 56:1779–1780
Lofberg M, Jankala H, Paetau A, Harkonen M, Somer H (1998) Metabolic causes of recurrent rhabdomyolysis. Acta Neurol Scand 98(4):268–75
LoCurto MJ (1997) The serotonin syndrome. Emerg Med Clin North Am 15(3):665–75
Martin-Du Pan RC, Morris MA, Favre H, Junod A, Pizzolato GP, Bottani A (1999) Mitochondrial anomalies in a Swiss family with autosomal dominant myoglobinuria. Am J Med Genet 14; 69(4):365–9
Mastaglia FL (1992) Toxic myopathies. In: Rowland LP, DiMauro S (eds) Handbook of clinical neurology. Vol. 62. Amsterdam, North Holland, pp 595–622
Meinck HM, Goebel HH, Rumpf KW, Kaiser H, Neumann P (1982) The forearm ischemic work test—hazardous to McArdle patients? J Neurol Neurosurg Psychiatry 45:1144–1146
Melberg A, Holme E, Oldfors A, Lundberg PO (1998) Rhabdomyolysis in autosomal dominant progressive external ophthalmoplegia. Neurology 50(1):299–300
Meyer-Betz F (1906) Beobachtungen an einem eigenartigen mit Muskellähmungen verbundenem Fall von Hämoglobinurie. Dtsch Arch Klin Med 1001:85–127
Miyajima H, Takahashi Y, Kaneko E (1995) Characterization of the glycolysis in lactate dehydrogenase-A deficiency. Muscle Nerve 18(8):874–8
Miller F, Friedman R, Tanenbaum J, Griffin A (1991) Disseminated intravascular coagulation and acute myoglobinuric renal failure: a consequence of the serotonergic syndrome. J Clin Psychopharmacol 11(4):277–9
Mills KC (1997) Serotonin syndrome. A clinical update. Crit Care Clin Oct;13(4):763–83
Monnier N, Procaccio V, Stieglitz P, Lunardi J (1997) Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive-type voltage-dependent calcium-channel receptor in skeletal muscle. Am J Hum Genet 60(6):1316–25
Nadel SM, Jackson JW, Ploth DW (1979) Hypokalemic rhabdomyolysis and acute renal failure. Occurrence following total parenteral nutrition. JAMA 241(21):2294–6
Nelson TE (2002) Malignant hyperthermia: a pharmacogenetic disease of Ca++ regulating proteins. Curr Mol Med 2(4):347–69
Ogilvie I, Pourfarzam M, Jackson S, Stockdale C, Bartlett K, Turnbull DM (1994) Very long-chain acyl coenzyme A dehydrogenase deficiency presenting with exercise-induced myoglobinuria. Neurology 44(3):467–73
Ohno K, Tanaka M, Sahashi K et al. (1991) Mitochondrial DNA deletions in inherited recurrent myoglobinuria. Ann Neurol 29(4):364–9
Preedy VR, Adachi J, Ueno Y et al. (2001) Alcoholic skeletal muscle myopathy: definitions, features, contribution of neuropathy, impact and diagnosis. Eur J Neurol 8(6):677–87
Prockop LD, Engel WK, Shug AL (1983) Nearly fatal muscle carnitine deficiency with full recovery after replacement therapy. Neurology 33(12):1629–31
Quane KA, Healy JM, Keating KE et al. (1993) Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat Genet 5(1):51–5
Ramesh V, Gardner-Medwin D (1992) Familial paroxysmal rhabdomyolysis: management of two cases of the non-exertional type. Dev Med Child Neurol 34(1):73–9
Richards JR (2000) Rhabdomyolysis and drugs of abuse. J Emerg Med 19(1):51–6
Riggs J (1998) Alcohol-associated rhabdomyolysis: ethanol induction of cytochrome P450 may potentiate myotoxicity. Clin Neuropharmacol 21(6):363–4
Ruitenbeek W, Poels PJ, Turnbull DM, Garavaglia B, Chalmers RA, Taylor RW, Gabreels FJ (1995) Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency. J Neurol Neurosurg Psychiatry 58(2):209–14
Rumpf KW, Kaiser H, Schulze F, Koop H, Trapp VE (1981) Myoglobinuria in malabsorption after small bowel resection. Med Klin 76(20):563–4
Saudubray JM, Martin D, de Lonlay P et al. (1999) Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 22(4):488–502
Schwengel D, Ludwig S (1985) Rhabdomyolysis and myoglobinuria as manifestations of child abuse. Pediatr Emerg Care 1(4):194–7
Shumate JB, Katnik R, Ruiz M, Kaiser K, Frieden C, Brooke MH, Carroll JE (1979) Myoadenylate deaminase deficiency. Muscle Nerve 2(3):213–6
Singh U, Scheld WM (1996) Infectious etiologies of rhabdomyolysis: three case reports and review. Clin Infect Dis. 22(4):642–9
Singhal PC, Abramovici M, Venkatesan J (1990) Rhabdomyolysis in the hyperosmolal state. Am J Med 88(1):9–12
Slater MS, Mullins RJ (1998) Rhabdomyolysis and myoglobinuric renal failure in trauma and surgical patients: a review. J Am Coll Surg 186(6):693–716
Steinfath M, Wappler F, Scholz J (2002) Malignant hyperthermia. General, clinical and experimental aspects. Anaesthesist (4):328–45
Sultana SR, Byrne DJ (1996). 'Raver's' haematuria. J R Coll Surg Edinb 41(6):419–20
Tein I, Di Mauro S, Rowlan LP (1992) Myoglobinuria. In: Rowland LP, DiMauro S (eds) Handbook of clinical neurology. Vol. 62. Amsterdam, North Holland, pp 553–593
Thomas MA, Ibels LS (1985) Rhabdomyolysis and acute renal failure. Aust N Z J Med 15(5):623–8
Tonin P, Lewis P, Servidei S, DiMauro S (1990) Metabolic causes of myoglobinuria. Ann Neurol 27(2):181–5
Tsurui S, Sugie H, Ito M, Igarashi Y (1995) Clinical and biochemical analysis of 27 patients with myoglobinuria of unknown causes. Rinsho Shinkeigaku 35(1):24–8
Urbano-Marquez A, Estruch R, Navarro-Lopez F, Grau JM, Mont L, Rubin E (1989) The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med 16;320(7):409–15
Verrips A, Poels PJE, Gabreëls FJM (2002) Rhabdomyolysis and Myoglobinuria. In: Katitji B, Kaminski H, Preston DC, Ruff RL, Shapiro BE (Hrsg) Neuromuscular disorders in clinical practice. Butterworth-Heinemann, Boston, pp 1319–1333
Verzijl HT, van Engelen BG, Luyten JA et al. (1998) Genetic characteristics of myoadenylate deaminase deficiency. Ann Neurol 44(1):140–3
Visweswaran P, Guntupalli J (1999) Rhabdomyolysis. Crit Care Clin 15(2):415–28
Vladutiu GD, Hogan K, Saponara I, Tassini L, Conroy J (1993) Carnitine palmitoyl transferase deficiency in malignant hyperthermia. Muscle Nerve 16(5):485–91
Warren JD, Blumbergs PC, Thompson PD (2002) Rhabdomyolysis: a review. Muscle Nerve 25(3):332–47
Wieser T, Deschauer M, Olek K, Hermann TH, Zierz S (2003) Carnitine palmitoyltransferase II deficiency – molecular and biochemical analysis of 32 patients. Neurology 60(8):1351–3
Zager RA (1996) Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int. 49(2):314–26
Zierz S, Engel AG (1985) Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscle. Eur J Biochem 15;149(1):207–14
Zierz S, Jerusalem F (1989) Mitochondrial myopathies and encephalomyelopathies. Nervenarzt 60(7):394–400
Zierz S (1994) Carnitine palmitoyltransferase deficiency. In: Engel AG, Franzini-Armstrong C (eds) Myology, Vol 2. Mc-Graw-Hill, New York, pp 1577–1586
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lindner, A., Zierz, S. Rhabdomyolyse und Myoglobinurie. Nervenarzt 74, 505–515 (2003). https://doi.org/10.1007/s00115-003-1518-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00115-003-1518-1